Biotech · Private company
Meiji Seika Pharma Co., Ltd.
Track this companyFree. Adds Meiji Seika Pharma Co., Ltd. to your Dealase workspace and tells you when its record changes.
Clinical trials42 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- Matching Vehicle SolutionPhase 2 · OnychomycosisClinicalTrials.gov · fetched Nov 12, 2026
- ME1111 Solution, High strengthPhase 2 · OnychomycosisClinicalTrials.gov · fetched Nov 12, 2026
- ME1111 Solution, Low strengthPhase 2 · OnychomycosisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- A Study of Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK)PHASE2 · RECRUITING · started Dec 2, 2025ClinicalTrials.gov NCT07116031 · fetched Nov 12, 2026
- A Study to Test How Effective Belumosudil Tablets Are for Treating Adult Participants With Chronic Lung Allograft DysfunctionPHASE3 · RECRUITING · started Oct 10, 2023ClinicalTrials.gov NCT06082037 · fetched Nov 12, 2026
- Efficacy, Safety, and Immunogenicity of Subcutaneous DMB-3115 Versus Stelara® in Patients With Moderate to Severe Chronic Plaque PsoriasisPHASE3 · COMPLETED · started Apr 28, 2021ClinicalTrials.gov NCT04785326 · fetched Nov 12, 2026
- Efficacy and Safety Study of ME1111 in Patients With OnychomycosisPHASE2 · COMPLETED · started Dec 19, 2013ClinicalTrials.gov NCT02022215 · fetched Nov 12, 2026